| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2021 | A novel anti-tumor/anti-tumor-associated fibroblast/anti-mPEG tri-specific antibody to maximize the efficacy of mPEGylated nanomedicines against fibroblast-rich solid tumor | Chen, M; Sheu, MT; Cheng, TL; Roffler, SR ; Lin, SY; Chen, YJ; Cheng, YA; Cheng, JJ; Chang, HY; Wu, TY; Kao, AP; Ho, YS; Chuang, KH | Biomaterials science 10(1), 202-215 | | | |
| 2021 | Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity | Ho, KW; Chen, IU; Cheng, YA; Liao, TY; Liu, ES; Chen, HJ; Lu, YC; Su, YC; Roffler, SR ; Huang, BC; Liu, HJ; Huang, MY; Chen, CY; Cheng, TL | Journal of nanobiotechnology 19, 16 | | | |
| 2019 | Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer. | Cheng, YA; Chen, IJ; Su, YC; Cheng, KW; Lu, YC; Lin, WW; Hsieh, YC; Kao, CH; Chen, FM; Roffler, SR ; Cheng, TL | Biomaterials science 7(8), 3404-3417 | | | |
| 2017 | Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules. | Lin, WW; Cheng, YA; Kao, CH; Roffler, SR ; Lee, YC; Chen, BM; Hsieh, YC; Chen, IJ; Huang, BC; Wang, YT; Tung, YC; Huang, MY; Chen, FM; Cheng, TL | ANALYTICAL CHEMISTRY 89(11), 6082-6090 | | | |
